Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage

Journal of Immunology

Volumn 181, Issue 1, 2008, Pages 698-711

  Chan, Gary ^a   Bivins Smith, Elizabeth R ^b   Smith, M Shane ^c   Smith, Patrick M ^a   Yurochko, Andrew D ^a,b  

^a Center for Molecular and Tumor Virology   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; TRANSCRIPTOME; 1 PALMITOYL 2 OLEOYL PHOSPHATIDYL URIDINE; 1-PALMITOYL-2-OLEOYL-PHOSPHATIDYL-URIDINE; CELL ADHESION MOLECULE; CYTOKINE; DRUG DERIVATIVE; PHOSPHATIDIC ACID; URIDINE;

ARTICLE; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; DNA MICROARRAY; GENE EXPRESSION PROFILING; HUMAN CYTOMEGALOVIRUS; LEUKOCYTE ACTIVATION; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEOMICS; TRANSCRIPTOMICS; VIRUS CELL INTERACTION; CELL ADHESION; CELL CULTURE; CYTOLOGY; CYTOMEGALOVIRUS; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PHENOTYPE; UPREGULATION;

CELL ADHESION; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; CYTOMEGALOVIRUS; GENE EXPRESSION PROFILING; HUMANS; MACROPHAGES; MONOCYTES; PHENOTYPE; PHOSPHATIDIC ACIDS; TRANSCRIPTION, GENETIC; UP-REGULATION; URIDINE;

EID: 47949091727     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.1.698     Document Type: Article

References (82)

1. Masur, H., S. M. Whitcup, C. Cartwright, M. Polis, and R. Nussenblatt. 1996. Advances in the management of AIDS-related cytomegalovirus retinitis. Ann. Intern. Med. 125: 126-136.
2. Ho, M. 1977. Virus infections after transplantation in man: brief review. Arch. Virol. 55: 1-24.
3. Stagno, S., R. F. Pass, M. E. Dworsky, R. E. Henderson, E. G. Moore, P. D. Walton, and C. A. Alford. 1982. Congenital cytomegalovirus infection: the relative importance of primary and recurrent maternal infection. N. Engl. J. Med. 306:945-949.
4. Sinzger, C, and G. Jahn. 1996. Human cytomegalovirus cell tropism and pathogenesis. Intervirology 39: 302-319.
5. Sinclair, J., and P. Sissons. 1996. Latent and persistent infections of monocytes and macrophages. Intervirology 39: 293-301.
6. Rice, G. P., R. D. Schrier, and M. B. Oldstone. I9S4. Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediateearly gene products. Proc. Natl. Acad. Sci. USA 81: 6134-6138.
7. Soderberg-Naucler, C, D. N. Streblow, K. N. Fish, J. Allan-Yorke, P. P. Smith, and J. A. Nelson. 2001. Reactivation of latent human cytomegalovirus in CD14+ monocytes is differentiation dependent. J. Virol. 75: 7543-7554.
8. Pulliam, L. 1991. Cytomegalovirus preferentially infects a monocyte derived macrophage/microglial cell in human brain cultures: neuropathology differs between strains. J. Neuropathol. Exp. Neurol. 50: 432-440.
9. Booss, J., P. R. Dann, B. P. Griffith, and J. H. Kim. 1989. Host defense response to cytomegalovirus in the central nervous system: predominance of the monocyte. Am. J. Pathol. 134: 71-78.
10. Degre, M. 2002. Has cytomegalovirus infection any role in the development of atherosclerosis? Clin. Microbiol. Infect. 8: 191-195.
11. Streblow, D. N., S. L. Orloff, and J. A. Nelson. 2001. Do pathogens accelerate atherosclerosis? J. Nutr. 131: 2798S-2804S.
12. van der Strate, B. W., J. L. Hillebrands, S. S. Lyeklama a Nijeholt, L. Beljaars, C. A. Bruggeman, M. J. Van Luyn, J. Rozing, T. H. The, D. K. Meijer, G. Molema, and M. C. Harmsen. 2003. Dissemination of rat cytomegalovirus through infected granulocytes and monocytes in vitro and in vivo. J. Virol. 77: 11274-11278.
13. Bale, J. F., Jr., and M. E. O'Neil. 1989. Detection of murine cytomegalovirus DNA in circulating leukocytes harvested during acute infection of mice. J. Virol. 63: 2667-2673.
14. Smith, M. S., G. L. Bentz, P. M. Smith, E. R. Bivins, and A. D. Yurochko. 2004. HCMV activates PI(3)K in monocytes and promotes monocyte motility and transendothelial migration in a PI(3)K-dependent manner. J. Leukocyte Biol. 76: 65-76.
15. Smith, M. S., G. L. Bentz, J. S. Alexander, and A. D. Yurochko. 2004. Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J. Virol. 78: 4444-4453.
16. Smith, M. S., E. R. Bivins-Smith, A. M. Tilley, G. L. Bentz, G. Chan, J. Minard, and A. D. Yurochko. 2007. Roles of phosphatidylinositol 3κinase and NFκB in human cytomegalovirus-mediated monocyte diapedesis and adhesion: strategy for viral persistence. J. Virol. 81: 7683-7694.
17. Bentz, G. L., M. Jarquin-Pardo, G. Chan, M. S. Smith, C. Sinzger, and A. D. Yurochko. 2006. Human cytomegalovirus (HCMV) infection of endothelial cells promotes naive monocyte extravasation and transfer of productive virus to enhance hematogenous dissemination of HCMV. J. Virol. 80: 11539-11555.
18. Shnyra, A., R. Brewington, A. Alipio, C. Amura, and D. C. Morrison. 1998. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12. J. Immunol. 160: 3729-3736.
19. Zhang, X., and D. C. Morrison. 1993. Lipopolysaccharide-induced selective priming effects on tumor necrosis factor alpha and nitric oxide production in mouse peritoneal macrophages. J. Exp. Med. 177: 511-516.
20. Redente, E. F., D. J. Orlicky, R. J. Bouchard, and A. M. Malkinson. 2007. Tumor signaling to the bone marrow changes the phenotype of monocytes and pulmonary macrophages during urethane-induced primary lung tumorigenesis in A/J mice. Am. J. Pathol. 170: 693-708.
21. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3: 23-35.
22. Nathan, C. F., H. W. Murray, M. E. Wiebe, and B. Y. Rubin. 1983. Identification of interferon-gamma as the Iymphokine that activates human macrophage oxi-dative metabolism and antimicrobial activity. J. Exp. Med. 158: 670-689.
23. Stein, M., S. Keshav, N. Harris, and S. Gordon. 1992. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176: 287-292.
24. Verreck, F. A., T. de Boer, D. M. Langenberg, M. A. Hoeve, M. Kramer, E. Vaisberg, R. Kastelein, A. Kolk, R. de Waal-Malefyt, and T. H. Ottenhoff. 2004. Human lL-23-producing type I macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. USA 101: 4560-4565.
25. Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and A. Sica. 2002. Macrophage polarization: tumorαssociated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23: 549-555.
26. Goerdt, S., and C. E. Orfanos. 1999. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10: 137-142.
27. Mosser, D. M. 2003. The many faces of macrophage activation. J. Leukocyte Biol. 73: 209-212.
28. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259: 1739-1742.
29. Jorgensen, P. F., J. E. Wang, M. Almlof, C. Thiemermann, S. J. Foster, R. Solberg, and A. O. Aasen. 2001. Peptidoglycan and lipoteichoic acid modify monocyte phenotype in human whole blood. Clin. Diagn. Lab. Immunol. 8: 515-521.
30. 2 by human blood monocytes subsequent to interaction with different bacterial derived agents. Lymphokine Res. 9: 449-463.
31. + monocytes that develop with RANKL into functional osteoclasts. J. Bone Miner. Res. 21: 193-206.
32. Hakkert, B. C, T. W. Kuijpers, J. F. Leeuwenberg, J. A. van Mourik, and D. Roos. 1991. Neutrophil and monocyte adherence to and migration across monolayers of cytokine-activated endothelial cells: the contribution of CD 18, ELAM-I, and VLA-4. Blood 78: 2721-2726.
33. Yurochko, A. D., and E. S. Huang. 1999. Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression. J. Immunol. 162: 4806-4816.
34. Zhu, H., J. P. Cong, D. Yu, W. A. Bresnahan, and T. E. Shenk. 2002. Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc. Natl. Acad. Sci. USA 99: 3932-3937.
35. Mocarski, E. S., Jr. 2002. Virus self-improvement through inflammation: no pain, no gain. Proc. Natl. Acad. Sci. USA 99: 3362-3364.
36. Stein, J., H. D. Volk, C. Liebenthal, D. H. Kruger, and S. Prosch. 1993. Tumour necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells. J. Gen. Virol. 74: 2333-2338.
37. Ritter, T., C. Brandt, S. Prosch, A. Vergopoulos, K. Vogt, J. Kolls, and H. D. Volk. 2000. Stimulatory and inhibitory action of cytokines on the regulation of hCMV-IE promoter activity in human endothelial cells. Cytokine 12: 1163-1170.
38. Locati, M, U. Deusehle, M. L. Massardi, F. O. Martinez, M. Sironi, S. Sozzani, T. Bartfai, and A. Mantovani. 2002. Analysis of the gene expression profile activated by the CC chemokine Iigand 5/RANTES and by Iipopolysaccharide in human monocytes. J. Immunol. 168: 3557-3562.
39. Mehta, A., R. Brewington, M. Chatterji, M. Zoubine, G. T. Kinasewitz, G. T. Peer, A. C. Chang, F. B. Taylor, Jr., and A. Shnyra. 2004. Infection-induced modulation of ml and m2 phenotypes in circulating monocytes: role in immune monitoring and early prognosis of sepsis. Shock 22: 423-430.
40. Goldmann, O., M. von Kockritz-Blickwede, C. Holtje, G. S. Chhatwal, R. Geffers, and E. Medina. 2007. Transcriptome analysis of murine macrophages in response to infection with Streptococcus pyogenes reveals an unusual activation program. Infect, Immum. 75: 4148-4157.
41. Yurochko, A. D., D. Y. Liu, D. Eierman, and S. Haskill. 1992. Integrins as a primary signal transduction molecule regulating monocyte immediate-early gene induction. Proc. Natl. Acad. Sci. USA 89: 9034-9038.
42. Browne, E. P., B. Wing, D. Coleman, and T. Shenk. 2001. Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs. J. Virol. 75: 12319-12330.
43. Zhu, H., J. P. Cong, G. Mamtora, T. Gingeras, and T. Shenk. 1998. Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonu-cleotide arrays. Proc. Natl. Acad. Sci. USA 95: 14470-14475.
44. Zhu, H., Y. Shen.and T. Shenk. 1995. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol. 69: 7960-7970.
45. Amoult, D., L. M. Bartle, A. Skaletskaya, D. Poncet, N. Zamzami, P. U. Park, J. Sharpe, R. J. Youle, and V. S. Goldmacher. 2004. Cytomegalovirus cell death suppressor vMIA blocks Bax-but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria. Proc. Natl. Acad. Sci. USA 101: 7988-7993.
46. Skaletskaya, A., L. M. Bartle, T. Chittenden, A. L. McCormick, E. S. Mocarski, and V. S. Goldmacher. 2001. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc. Natl. Acad. Sci. USA 98: 7829-7834.
47. Martinez, F. O., S. Gordon, M. Locati, and A. Mantovani. 2006. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177: 7303-7311.
48. Liu, S. F., and A. B. Malik. 2006. NFκB activation as a pathological mechanism of septic shock and inflammation. Am. J. Physiol. 290: L622-L645.
49. Shishodia, S., and B. B. Aggarwal. 2002. Nuclear factorκB activation: a question of life or death. J. Biochem. Mol. Biol. 35: 28-40.
50. Proost, P., A. Wuyts, and J. van Damme. 1996. The role of chemokines in inflammation. Int. J. Clin. Lab. Res. 26: 211-223.
51. Schenkel, A. R., Z. Mamdouh, and W. A. Muller. 2004. Locomotion of monocytes on endothelium is a critical step during extravasation. Nat. Immunol. 5: 393-400.
52. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314.
53. Liote, F., B. Boval-Boizard, D. Weill, D. Kuntz, and J. L. Wautier. 1996. Blood monocyte activation in rheumatoid arthritis: increased monocyte adhesiveness, integrin expression, and cytokine release. Clin. Exp. Immunol. 106: 13-19.
54. Mustjoki, S., R. Alitalo, E. Elonen, O. Carpen, C. G. Gahmberg, and A. Vaheri. 2001. Intercellular adhesion molecule-1 in extravasation of normal mononuclear and leukaemia cells. Br. J. Haematol. 113: 989-1000.
55. Shahgasempour, S., S. B. Woodroffe, and H. M. Garnett. 1997. Alterations in the expression of ELAM-I, ICAM-I and VCAM-I after in vitro infection of endothelial cells with a clinical isolate of human cytomegalovirus. Microbiol. Immunol. 41: 121-129.
56. Chan, G., M. F. Stinski, and L. J. Guilbert. 2004. Human cytomegalovirus-in-duced upregulation of intercellular cell adhesion molecule-1 on villous syncy-tiotrophoblasts. Biol. Reprod. 71: 797-803.
57. 1 expression and association with cell rounding in human cytomegalovirus-infected fibroblasts. J. Cen. Virol. 75: 3319-3325.
58. Ito, M., M. Watanabe, T. Ihara, H. Kamiya, and M. Sakurai. 1995. Increased expression of adhesion molecules (CD54, CD29 and CD44) on fibroblasts infected with cytomegalovirus. Microbiol. Immunol. 39: 129-133.
59. Pardo, A., and M. Selman. 2005. MMP-I: the elder of the family. Int. J. Biochem. Cell Biol. 37: 283-288.
60. Gill, J. H., I. G. Kirwan, J. M. Seargent, S. W. Martin, S. Tijani, V. A. Anikin, A. J. Meams, M. C. Bibby, A. Anthoney, and P. M. Loadman. 2004. MMP-10 is overexpressed, proteolytically active, and a potential target for therapeutic intervention in human lung carcinomas. Neoplasia 6: 777-785.
61. Mantovani, A., A, Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25: 677-686.
62. Doherty, D. E., L. Zagarella, P. M. Henson, and G. S. Worthen. 1989. Lipopoly-saccharide stimulates monocyte adherence by effects on both the monocyte and the endothelial cell. J. Immunol. 143: 3673-3679.
63. Van Damme, J., M. De Ley, J. Van Snick, C. A. Dinarello, and A. Billiau. 1987. The role of interferon-beta 1 and the 26κDa protein (interferon-beta 2) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor. J. Immunol. 139: 1867-1872.
64. Hughes, T. K., T. A. Kaspar, and D. H. Coppenhaver. 1988. Synergy of antiviral actions of TNF and IFN-gamma: evidence for a major role of TNF-induced IFN-beta. Antiviral Res. 10: 1-9.
65. Taylor-Wiedeman, J., J. G. Sissons, L. K. Borysiewicz, and J. H. Sinclair. 1991. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Cen. Virol. 72: 2059-2064.
66. Fish, K. N., A. S. Depto, A. V. Moses, W. Britt, and J. A. Nelson. 1995. Growth kinetics of human cytomegalovirus are altered in monocyte-derived macro-phages. J. Virol. 69: 3737-3743.
67. Ibanez, C. E., R. Schrier, P. Ghazal, C. Wiley, and J. A. Nelson. 1991. Human cytomegalovirus productively infects primary differentiated macrophages. J. Virol. 65: 6581-6588.
68. Yurochko, A. D. 2008. Human cytomegalovirus modulation of signal transduction. In Human Cytomegaloviruses. M. F. Stinski and T. Shenk, eds. Springer-Verlag, Berlin and Heidelberg, pp. 205-220.
69. Chan, G., E. R. Bivins-Smith, M. S. Smith, and A. D. Yurochko. 2008. Tran-scriptome analysis of NFκB- and phosphatidylinositol 3-kinase-regulated genes in human cytomegalovirus-infected monocytes. J. Virol. 82: 1040-1046.
70. Hirsch, E., V. M. Irikura, S. M. Paul, and D. Hirsh. 1996. Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc. Natl. Acad. Sci. USA 93: 11008-11013.
71. Salek-Ardakani, S., J. R. Arrand, and M. Mackett. 2002. Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV. Virology 304: 342-351.
72. Kotenko, S. V., S. Saccani, L. S. Izotova, O. V. Mirochnitchenko, and S. Pestka. 2000. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl. Acad. Sci. USA 97: 1695-1700.
73. Fiorentino, D. F A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Thl cells. J. Immunol. 146: 3444-3451.
74. Charo, I. F., and M. B. Taubman. 2004. Chemokines in the pathogenesis of vascular disease. Circ. Res. 95: 858-866.
75. Pulliam, L., B. Sun, and H. Rempel. 2004. Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load. J. Neuroimmunol. 157: 93-98.
76. Wen, W., S. Chen, Y. Cao, Y. Zhu, and Y. Yamamoto. 2005. HIV-1 infection initiates changes in the expression of a wide array of genes in U937 promonocytes and HUT78 T cells. Virus Res. 113: 26-35.
77. Giri, M. S., M. Nebozhyn, L. Showe, and L. J. Montaner. 2006. Microarray data on gene modulation by HIV-1 in immune cells: 2000-2006. J. Leukocyte Biol. 80: 1031-1043.
78. Izmailova, E., F. M. Bertley, Q. Huang, N. Makori, C. J. Miller, R. A. Young, and A. Aldovini. 2003. HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages. Nat. Med. 9: 191-197.
79. Choi, H. J., and T. E. Smithgall. 2004. HIV-1 Nef promotes survival of TF-1 macrophages by inducing Bcl-XL expression in an extracellular signal-regulated kinase-dependent manner. J. Biol. Chem. 279: 51688-51696.
80. Vazquez, N., T. Greenwell-Wild, N. J. Marinos, W. D. Swaim, S. Nares, D. E. Ott, U. Schubert, P. Henklein, J. M. Orenstein, M. B. Spom, and S. M. Wahl. 2005. Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation. J. Virol. 79: 4479-4491.
81. Zhang, M., X. Li, X. Pang, L. Ding, O. Wood, K. A. Clouse, I. Hewlett, and A. I. Dayton. 2002. Bcl-2 upregulation by HIV-1 Tat during infection of primary human macrophages in culture. J. Biomed. Sci. 9: 133-139.
82. Tuttle, D. L., J. K. Harrison, C. Anders, J. W. Sleasman, and M. M. Goodenow. 1998. Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1. J. Virol. 72: 4962-4969.